Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia

Int J Cardiol. 2014 Feb 1;171(2):272-3. doi: 10.1016/j.ijcard.2013.11.091. Epub 2013 Dec 4.
No abstract available

Keywords: Cardiovascular disease; Dyslipidemia; Hyperglycemia; IGF-1.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Apolipoproteins E / genetics
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism*
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / metabolism*
  • Disease Models, Animal
  • Dyslipidemias / complications
  • Dyslipidemias / metabolism*
  • Hyperglycemia / complications
  • Hyperglycemia / metabolism*
  • Insulin-Like Growth Factor I / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout

Substances

  • Apolipoproteins E
  • insulin-like growth factor-1, mouse
  • Insulin-Like Growth Factor I